Rates and Correlates of Uptake of Continuous Glucose Monitors Among Adults with Type 2 Diabetes in Primary Care and Endocrinology Settings
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Background Clinical trials indicate continuous glucose monitor (CGM) use may benefit adults with type 2 diabetes, but CGM rates and correlates in real-world care settings are unknown. Objective We sought to ascertain prevalence and correlates of CGM use and to examine rates of new CGM prescriptions across clinic types and medication regimens. Design Retrospective cohort using electronic health records in a large academic medical center in the Southeastern US. Participants Adults with type 2 diabetes and a primary care or endocrinology visit during 2021. Main Measures Age, gender, race, ethnicity, insurance, clinic type, insulin regimen, hemoglobin A1c values, CGM prescriptions, and prescribing clinic type. Key Results Among 30,585 adults with type 2 diabetes, 13% had used a CGM. CGM users were younger and more had private health insurance ( p < .05) as compared to non-users; 72% of CGM users had an intensive insulin regimen, but 12% were not taking insulin. CGM users had higher hemoglobin A1c values (both most recent and most proximal to the first CGM prescription) than non-users. CGM users were more likely to receive endocrinology care than non-users, but 23% had only primary care visits in 2021. For each month in 2021, a mean of 90.5 (SD 12.5) people started using CGM. From 2020 to 2021, monthly rates of CGM prescriptions to new users grew 36% overall, but 125% in primary care. Most starting CGM in endocrinology had an intensive insulin regimen (82% vs. 49% starting in primary care), whereas 28% starting CGM in primary care were not using insulin (vs. 5% in endocrinology). Conclusion CGM uptake for type 2 diabetes is increasing rapidly, with most growth in primary care. These trends present opportunities for healthcare system adaptations to support CGM use and related workflows in primary care to support growth in uptake.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Economic Costs of Diabetes in the U.S. in 2017
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dci18-0007 · Cited by 2,528
Trends in diabetes treatment and control in U.S. adults, 1999-2018
Fang, M., Wang, D., Coresh, J., & Selvin, E. (2021) · New England Journal of Medicine · doi:10.1056/nejmsa2032271 · Cited by 690
Beck, R. W., Riddlesworth, T. D., Ruedy, K., Ahmann, A., Haller, S., Kruger, D., McGill, J. B., Polonsky, W., Price, D., Aronoff, S., et al. (2017) · Annals of Internal Medicine · doi:10.7326/m16-2855 · Cited by 635
Martens, T., Beck, R. W., Bailey, R., Ruedy, K. J., Calhoun, P., Peters, A. L., Pop-Busui, R., Philis-Tsimikas, A., Bao, S., Umpierrez, G., et al. (2021) · JAMA · doi:10.1001/jama.2021.7444 · Cited by 543
Perrin, N. E., Davies, M. J., Robertson, N., Snoek, F. J., & Khunti, K. (2017) · Diabetic Medicine · doi:10.1111/dme.13448 · Cited by 495
Peters, A. L., Ahmann, A. J., Battelino, T., Evert, A., Hirsch, I. B., Murad, M. H., Winter, W. E., & Wolpert, H. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2534 · Cited by 250
7. Diabetes Technology: Standards of Medical Care in Diabetes—2019
American Diabetes Association (2019) · Diabetes Care · doi:10.2337/dc19-s007 · Cited by 179
DeSalvo, D. J., Noor, N., Xie, C., Corathers, S. D., Majidi, S., McDonough, R. J., Polsky, S., Izquierdo, R., Rioles, N., Weinstock, R., et al. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968211049783 · Cited by 113
Cox, D. J., Banton, T., Moncrief, M., Conaway, M., Diamond, A., & McCall, A. L. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa118 · Cited by 82
Cited by
Ebekozien, O., Fantasia, K., Farrokhi, F., Sabharwal, A., & Kerr, D. (2024) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.15470 · Cited by 70
“89 Similarly, younger age and endocrinologist visits have been associated with greater likelihood of insulin pump initiation in T2D.”
BackgroundShields, S., Thomas, R., Durham, J., Moran, J., Clary, J., & Ciemins, E. L. (2024) · Scientific Reports · doi:10.1038/s41598-024-83548-4 · Cited by 28
Practical Approaches to Continuous Glucose Monitoring in Primary Care: A UK-Based Consensus Opinion
Fernando, K., Alabraba, V., Welsh, J. B., Seidu, S., Strain, W. D., Bell, H. E., Davies, S., & Evans, M. (2025) · Diabetes Therapy · doi:10.1007/s13300-025-01706-x · Cited by 7
Knopp, M. I., Castleman, A. M., Schwarz, A., Belger-Wallace, J., Falciglia, M., Zuzek, A., & Mendonca, E. (2025) · JMIR Diabetes · doi:10.2196/73446 · Cited by 2
Metadata
- Authors
- Mayberry, L. S., Guy, C., Hendrickson, C. D., McCoy, A. B., & Elasy, T.
- Venue
- Journal of General Internal Medicine
- Published
- 2023-05-30
- Volume
- 38
- Issue
- 11
- Pages
- 2546-2552
- ISSN
- 0884-8734 (ISSN-L)
- 1525-1497
- OpenAlex
- W4378781361
- Cited by
- 77
- References
- 9
- FWCI
- 12.74
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Rates and Correlates of Uptake of Continuous Glucose Monitors Among Adults with Type 2 Diabetes in Primary Care and Endocrinology Settings. https://app.cochat.ai/papers/10.1007/s11606-023-08222-3
- The paper
- Mayberry, L. S., Guy, C., Hendrickson, C. D., McCoy, A. B., & Elasy, T. (2023). Rates and Correlates of Uptake of Continuous Glucose Monitors Among Adults with Type 2 Diabetes in Primary Care and Endocrinology Settings. Journal of General Internal Medicine. https://doi.org/10.1007/s11606-023-08222-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.